Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

An expert panel of the Central Drugs Standard Control Organisation on Monday recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for......

5 more manufacturers to produce black fungus drug: Govt

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

It is one of 42 drug-making factories in India that the FDA has banned in recent years The US Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying......

How Much Have MFs Invested In HDFC Bank?

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore. Photograph: Anushree Fadnavis/Reuters   Mutual......

Actavis eyes Emcure unit, three others for buyout

Iceland's Actavis Pharma is in talks to acquire the pharma division of Pune-based Emcure Pharmaceuticals as part of its Indian business expansion plan.Emcure is among the four Indian companies......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......